The European Commission has cleared Talanx and Meiji Yasuda Life Insurance’s proposed acquisition of joint control over Towarzystwo UbezpieczeÅ„ i Reasekuracji Warta. Talanx is a subsidiary of German insurance company HDI; Meiji Yasuda is a Japanese insurance company. Warta is part of the Belgian KBC Group, but KBC is required to sell Warta pursuant to a state aid restructuring plan approved by the European Commission.
The acquisition was cleared because “the parties would have only a moderate combined market presence [and] the addition in market share resulting from the transaction is negligible.”
Full content: EC Press Release
Related content: Is a Safe Harbour for Insurance Still Justified? (Eithne McCarthy, European Commission)
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas